U.S. market Closed. Opens in 16 hours 2 minutes

AGL | agilon health, inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue4.32B2.71B1.83B1.22B794.41M
Cost of Revenue4.26B2.60B1.76B1.12B765.90M
Gross Profit53.63M112.29M76.41M94.15M28.51M
Operating Expenses285.57M218.94M470.37M150.82M135.09M
Selling, General & Admin285.57M218.94M455.82M137.29M122.83M
Research & DevelopmentN/AN/AN/AN/AN/A
Other Operating Expenses27.84M24.73M14.54M13.53M12.25M
Operating Income-231.94M-110.21M-393.95M-56.67M-106.57M
Other Expenses / Income37.48M4.53M-10.65M-5.67M-8.11M
Before Tax Income-194.46M-105.69M-404.60M-62.34M-114.69M
Income Tax Expenses791.00K1.18M886.00K865.00K-232.00K
Net Income-215.05M-106.86M-405.48M-63.21M-114.45M
Interest Expenses6.66M-4.53M6.15M8.13M9.07M
Basic Shares Outstanding408.92M408.15M400.10M390.83M390.83M
Diluted Shares Outstanding408.92M408.15M400.10M390.83M390.83M
EBITDA-211.78M-96.44M-383.78M-40.11M-64.21M
EBITDA Margin-4.91%-3.56%-20.93%-3.29%-8.08%
EBIT-207.60M-110.21M-398.45M-54.21M-105.62M
EBIT Margin-4.81%-4.07%-21.73%-4.45%-13.30%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙